Estimating Hypothetically Negotiated Royalty Rates After MedImmune, Inc. v Genentech, Inc. et al
$25.00v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
Showing all 2 results

v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008

v15i1: pp. 93-104 David Boyd; Thomas R. Ireland Antitrust 2008
A note on quantifying the tax advantage of structured versus lump-sum settlements
1 × $25.00
Decompositions of 1 That Incorporate Growth
1 × $25.00
Measuring household production: Methodological considerations and current practice
1 × $25.00
Damages under wrongful death statutes: The relevancy of a survivor�s nation of residency
1 × $25.00 Subtotal: $100.00